Passage Bio
Bin Lu, PhD is a Senior Scientist at Passage Bio with a focus on developing gene therapy manufacturing processes for CNS genetic disorders. Prior to this, Bin worked at Spark Therapeutics, Inc. as a Scientist specializing in downstream process development for gene therapy products. Bin also has experience as a Research Scientist at A*STAR Bioprocessing Technology Institute, where they conducted research on apoptosis-related genes and protein expression regulation. Bin holds a Ph.D in Biochemistry, Biophysics, and Molecular Biology from Iowa State University.
This person is not in the org chart
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).